Advertisement

Evolution and Dosimetric Analysis of Magnetic Resonance Imaging–Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma

      Purpose

      To evaluate the evolution of radiation-induced brain stem injury (BSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity modulated radiation therapy (IMRT) and to identify the critical dosimetric predictors of BSI.

      Methods and Materials

      A total of 6288 NPC patients treated with IMRT between 2009 and 2015 were retrospectively reviewed. Among these 6288 patients, 24 had radiation-induced BSI, which manifested as edematous lesions and contrast-enhanced lesions (CLs) on magnetic resonance imaging. Latency, symptoms, and evolution of BSI were assessed. Critical dosimetric predictors of BSI were identified using a penalized regression model with performance evaluated by receiver operating characteristic curve analysis.

      Results

      Median BSI latency was 14.5 months (range, 7.6-37.5 months), and 9 out of 24 patients (37.5%) were clinically symptomatic. Edematous lesions and CLs were both present in all patients. Necrosis was significantly more common in larger CLs (P = .007). After median follow-up of 12.5 months, 13 out of 24 patients (54.2%) had complete remission, and 5 out of 24 patients (20.8%) had partial remission. Remission was unaffected by whether or not symptomatic treatment was given. Maximum point dose (Dmax) was identified as the critical predictor of BSI (area under the receiver operating curve = 0.898), with the optimal cutoff equivalent dose in 2-Gy fractions (D2) being 67.4 Gy (sensitivity = 0.833, 20 out of 24; specificity = 0.835, 5234 out of 6264). Patients with Dmax ≥67.4 Gy (D2) were significantly more likely to develop BSI (odds ratio = 25.29; 95% CI, 8.63-74.14; P < .001) than those with Dmax <67.4 Gy (D2).

      Conclusions

      In patients with NPC treated with IMRT, BSI generally tends to improve over time. Dmax = 67.4 Gy (D2) appears to be the dose constraint for brain stem, potentially providing clinicians with greater choice and flexibility when balancing the tumor target coverage and brain stem protection. Further studies are needed to validate our findings.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Boden G.
        Radiation myelitis of the brain-stem.
        J Fac Radiologists. 1950; 2: 79-94
        • Lin S.
        • Pan J.
        • Han L.
        • Zhang X.
        • Liao X.
        • Lu J.J.
        Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: Report on the 3-yr outcome of a prospective series.
        Int J Radiat Oncol Biol Phys. 2009; 75: 1071-1078
        • Li Y.C.
        • Chen F.P.
        • Zhou G.Q.
        • et al.
        Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma.
        ORAL ONCOL. 2017; 73: 97-104
        • Marks L.B.
        • Yorke E.D.
        • Jackson A.
        • et al.
        Use of normal tissue complication probability models in the clinic.
        Int J Radiat Oncol Biol Phys. 2010; 76: S10-S19
        • Mayo C.
        • Yorke E.
        • Merchant T.E.
        Radiation associated brainstem injury.
        Int J Radiat Oncol Biol Phys. 2010; 76: S36-41
        • Schipani S.
        • Jain R.
        • Shah K.
        • et al.
        Clinical, dosimetric, and radiographic correlation of radiation injury involving the brainstem and the medial temporal lobes following stereotactic radiotherapy for neoplasms of central skull base.
        J Neurooncol. 2010; 98: 177-184
        • Uy N.W.
        • Woo S.Y.
        • Teh B.S.
        • et al.
        Intensity-modulated radiation therapy (IMRT) for meningioma.
        Int J Radiat Oncol Biol Phys. 2002; 53: 1265-1270
        • Debus J.
        • Hug E.B.
        • Liebsch N.J.
        • et al.
        Brainstem tolerance to conformal radiotherapy of skull base tumors.
        Int J Radiat Oncol Biol Phys. 1997; 39: 967-975
        • Wei K.R.
        • Zheng R.S.
        • Zhang S.W.
        • Liang Z.H.
        • Li Z.M.
        • Chen W.Q.
        Nasopharyngeal carcinoma incidence and mortality in China, 2013.
        Chin J Cancer. 2017; 36: 90
        • Huang X.D.
        • Zhou G.Q.
        • Lv J.W.
        • et al.
        Competing Risk Nomograms for Nasopharyngeal Carcinoma in the Intensity-modulated Radiotherapy Era: a Big-data, Intelligence Platform-based Analysis.
        Radiother Oncol. 2018; 129: 389-395
        • Lee N.
        • Harris J.
        • Garden A.S.
        • et al.
        Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225.
        J Clin Oncol. 2009; 27: 3684-3690
        • Lee N.Y.
        • Zhang Q.
        • Pfister D.G.
        • et al.
        Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): A phase 2 multi-institutional trial.
        Lancet Oncol. 2012; 13: 172-180
        • Edge S.B.
        • Compton C.C.
        The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM.
        Ann Surg Oncol. 2010; 17: 1471-1474
        • Wang Y.X.
        • King A.D.
        • Zhou H.
        • et al.
        Evolution of radiation-induced brain injury: MR imaging-based study.
        Radiology. 2010; 254: 210-218
        • Mao Y.P.
        • Zhou G.Q.
        • Liu L.Z.
        • et al.
        Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.
        Br J Cancer. 2014; 110: 2633-2639
        • Meeks S.L.
        • Buatti J.M.
        • Foote K.D.
        • Friedman W.A.
        • Bova F.J.
        Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery.
        Int J Radiat Oncol Biol Phys. 2000; 47: 597-602
      1. Amin M.B. American Joint Committee on Cancer Staging Manual. 8th ed. Springer, New York, NY2017
        • Riggs J.E.
        • Schochet S.J.
        Osmotic stress, osmotic myelinolysis, and oligodendrocyte topography.
        Arch Pathol Lab Med. 1989; 113: 1386-1388
        • Coderre J.A.
        • Morris G.M.
        • Micca P.L.
        • et al.
        Late effects of radiation on the central nervous system: Role of vascular endothelial damage and glial stem cell survival.
        Radiat Res. 2006; 166: 495-503
        • Yao C.Y.
        • Zhou G.R.
        • Wang L.J.
        • et al.
        A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: Radiation-induced brainstem injury and dose-volume analysis.
        Radiat Oncol. 2018; 13: 194
        • Al-Mefty O.
        • Kersh J.E.
        • Routh A.
        • Smith R.R.
        The long-term side effects of radiation therapy for benign brain tumors in adults.
        J Neurosurg. 1990; 73: 502-512
        • Zhou G.Q.
        • Yu X.L.
        • Chen M.
        • et al.
        Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: A comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy.
        PLoS One. 2013; 8e67488
        • Lee A.W.
        • Kwong D.L.
        • Leung S.F.
        • et al.
        Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.
        Int J Radiat Oncol Biol Phys. 2002; 53: 75-85
        • Williamson R.
        • Kondziolka D.
        • Kanaan H.
        • Lunsford L.D.
        • Flickinger J.C.
        Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: A pilot study.
        Stereotact Funct Neurosurg. 2008; 6: 359-366
        • Delanian S.
        • Lefaix J.L.
        • Maisonobe T.
        • Salachas F.
        • Pradat P.F.
        Significant clinical improvement in radiation-induced lumbosacral polyradiculopathy by a treatment combining pentoxifylline, tocopherol, and clodronate (Pentoclo).
        J Neurol Sci. 2008; 275: 164-166
        • De Ruyck K.
        • Sabbe N.
        • Oberije C.
        • et al.
        Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy.
        Int J Radiat Oncol Biol Phys. 2011; 81: 537-544
        • Lee T.-F.
        • Chao P.-J.
        • Ting H.-M.
        • et al.
        Using multivariate regression model with Least Absolute Shrinkage and Selection Operator (LASSO) to predict the incidence of xerostomia after intensity-modulated radiotherapy for head and neck cancer.
        PLoS One. 2014; 9e89700
        • Kong C.
        • Zhu X.
        • Lee T.
        • et al.
        LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
        Sci Rep. 2016; 6: 26378

      Linked Article

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.